Christine Betard and Dr. Judith Abdalla are Executive Directors, Global Strategic Drug Development, within Quintiles Innovation Unit.

Christine's focus is on providing drug development expertise to support strategic business activities by offering specialist knowledge to strategic product development and risk management from first in man to post approval.

Judith plays a key role in strategic partnerships, in designing innovative models of drug development, in conducting due diligence for Quintiles and external investors, and in advising customers, internal and external, on how best to develop compounds into commercially successful drugs to maximise their value.

In this presentaton they share their knowledge on the use of biomarkers in compound development in clinical trials.